D83
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either sex aged at least 18 years of age with a current diagnosis of CVID (according to the European Society for Immunodeficiencies [ESID] criteria), receiving regular IgG replacement therapy.
Exclusion criteria
Exclusion criteria: Patients who meet the following criteria will be excluded from the analyses: currently receiving treatment with immunosuppressive drugs or corticosteroid treatment with > 15 mg per day prednisolone or equivalent; previous bowel resection surgery; positive stool culture (after standard treatment); previous clinically relevant hypersensitivity to IgG treatment; concomitant illness that in the opinion of the investigator would affect the study analyses; or current or history of alcohol or drug abuse.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of chronic diarrhoea (the abnormal passage of 3 or more loose or liquid stools per day for more than 6 weeks out of the last 6 months) | — |
Countries
Germany
Contacts
Universitätsklinikum Freiburg